Tenofovir alafenamide
Inquiry
| Post Date: | Feb 09,2022 |
| Expiry Date: | Aug 08,2022 |
| Detailed Description: | Cas No. :379270-37-8 Tenofovir alafenamide (INN/USAN, formerly GS-7340) is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It was developed by Gilead Sciences for use in the treatment of HIV infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate (TAF). Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil, TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent. |
| CAS Registry Number: | 379270-37-8 |
| Synonyms: | ;GS-7340;TENOFOVIR ALAFENAMIDE;Tenofovir Alafenamide free base;Tenofovir alafenamide; |
| Molecular Formula: | C21H29N6O5P |
| Molecular Weight: | 476.47628 |
| Molecular Structure: | ![379270-37-8 N-[[S(P)]-[2-(Adenin-9-yl)-1(R)-methylethoxymethyl](phenoxy)phosphoryl]-L-alanine isopropyl ester](https://images.chemnet.com/suppliers/chembase/635/393635.wmf)
|
| Company: | Hangzhou Brown Bio-Pharm Co.,Ltd. [ China ] |
| Contact: | michelle xu |
| Tel: | 86-571-85381539 85381529-8035 |
| Fax: | 86-571-85022751 |
| Email: | sales@hzbrown.com/sales@chinaelion.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
